Table 1 The top 20 biological processes enriched by the 54 putative targets
Term | Count of Proteins | % | p -Value |
|---|---|---|---|
positive regulation of nitric oxide biosynthetic process | 14 | 25.93 | 2.12 × 10−23 |
inflammatory response | 20 | 37.04 | 1.89 × 10−18 |
positive regulation of transcription from RNA polymerase II promoter | 26 | 48.15 | 1.90 × 10−17 |
positive regulation of smooth muscle cell proliferation | 12 | 22.22 | 3.09 × 10−17 |
lipopolysaccharide-mediated signaling pathway | 10 | 18.52 | 4.01 × 10−16 |
positive regulation of gene expression | 16 | 29.63 | 1.99 × 10−15 |
response to drug | 16 | 29.63 | 1.76 × 10−14 |
cellular response to lipopolysaccharide | 12 | 22.22 | 4.69 × 10−14 |
response to lipopolysaccharide | 13 | 24.07 | 9.47 × 10−14 |
positive regulation of transcription, DNA-templated | 18 | 33.33 | 1.69 × 10−13 |
aging | 12 | 22.22 | 3.15 × 10−12 |
cellular response to organic cyclic compound | 9 | 16.67 | 1.11 × 10−11 |
angiogenesis | 12 | 22.22 | 8.27 × 10−11 |
positive regulation of protein phosphorylation | 10 | 18.52 | 2.04 × 10−10 |
movement of cell or subcellular component | 9 | 16.67 | 2.49 × 10−10 |
response to antibiotic | 7 | 12.96 | 6.28 × 10−10 |
negative regulation of apoptotic process | 14 | 25.93 | 1.12 × 10−9 |
cellular response to mechanical stimulus | 8 | 14.81 | 2.36 × 10−9 |
negative regulation of cell proliferation | 13 | 24.07 | 2.79 × 10−9 |
positive regulation of ERK1 and ERK2 cascade | 10 | 18.52 | 3.53 × 10−9 |